Skip to main content

Table 2 The risk factors for the 30-day mortality in FluA-CAP patients

From: The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study

Variable OR (95% CI) p-value
Cardiovascular disease 3.189 (1.300–7.892) < 0.001
Smoking history 3.294 (1.151–9.429) < 0.001
Lymphocytes < 0.8 × 109/L 4.080 (1.321–12.596) < 0.001
BUN > 7 mmol/L 2.158 (1.084–4.690) < 0.001
pO2/FiO2 ≤ 250 mmHg 4.344 (2.050–9.203) < 0.001
Early NAI therapy 0.415 (0.195–0.858) 0.001
  1. OR Odd ratio, CI Confidence interval